Surmodics reported $23.87M in Sales Revenues for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Sales Change
Abbott ABT:US $ 10223M 233M
Align Technology ALGN:US $ 1010.81M 116.04M
Anika Therapeutics ANIK:US $ 38.15M 3.85M
Arrowhead Research ARWR:US $ 45.89M 13.08M
Baxter International BAX:US $ 3098M 152M
Bioscrip BIOS:US $ 860.27M 101.04M
Boston Scientific BSX:US $ 3077M 325M
Cryolife CRY:US $ 76.15M 5.06M
Edap Tms EDAP:US $ 10.35M 0.05M
Edwards Lifesciences EW:US $ 1376M 159.4M
Genmark Diagnostics GNMK:US $ 50.08M 7.43M
Haemonetics HAE:US $ 228.53M 3.5M
Heron Therapeutics HRTX:US $ 22.44M 2.42M
Johnson & Johnson JNJ:US $ 23312M 991M
Merit Medical Systems MMSI:US $ 280.32M 31.41M
Mesa Laboratories MLAB:US $ 34.92M 3.04M
Nektar Therapeutics NKTR:US $ 28.33M 4.68M
Oxford Immunotec Global OXFD:US $ 19.44M 13.6M
Providence Service PRSC:US $ 474.45M 20.84M
Stryker SYK:US $ 4294M 341M
Surmodics SRDX:US $ 23.87M 11.12M